electroCore, Inc. (ECOR) stock
ECORNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$5.25−0.04 (-0.76%)
Close on Nov 13, 2026Market cap $47.33MP/E –Yield –
electroCore r&d expenses
Research and development expenses are spending on new products and technology.
electroCore's R&D Expenses for the twelve months ending Sep 30, 2025 was $2.62M, down 1.6% year over year. For fiscal 2024 it was $2.36M, down 55.6% from the year before. The highest annual figure on record is $12.47M in fiscal 2018.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $2.36M | -55.6% |
| FY2023 | Dec 31, 2023 | $5.32M | -3.6% |
| FY2022 | Dec 31, 2022 | $5.52M | +117.7% |
| FY2021 | Dec 31, 2021 | $2.54M | -39.6% |
| FY2020 | Dec 31, 2020 | $4.20M | -57.6% |
| FY2019 | Dec 31, 2019 | $9.90M | -20.6% |
| FY2018 | Dec 31, 2018 | $12.47M | +59.2% |
| FY2017 | Dec 31, 2017 | $7.83M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | $662.00K | +27.1% |
| Q2 FY2025 | Jun 30, 2025 | $511.00K | -19.5% |
| Q1 FY2025 | Mar 31, 2025 | $642.00K | +60.9% |
| Q4 FY2024 | Dec 31, 2024 | $805.00K | -27.3% |
| Q3 FY2024 | Sep 30, 2024 | $521.00K | -58.3% |
| Q2 FY2024 | Jun 30, 2024 | $635.00K | -45.0% |
| Q1 FY2024 | Mar 31, 2024 | $399.00K | -77.9% |
| Q4 FY2023 | Dec 31, 2023 | $1.11M | -31.9% |
| Q3 FY2023 | Sep 30, 2023 | $1.25M | -22.8% |
| Q2 FY2023 | Jun 30, 2023 | $1.16M | -13.9% |
| Q1 FY2023 | Mar 31, 2023 | $1.81M | +93.7% |
| Q4 FY2022 | Dec 31, 2022 | $1.63M | +119.4% |
| Q3 FY2022 | Sep 30, 2022 | $1.62M | +244.0% |
| Q2 FY2022 | Jun 30, 2022 | $1.34M | +62.5% |
| Q1 FY2022 | Mar 31, 2022 | $934.00K | +87.2% |
| Q4 FY2021 | Dec 31, 2021 | $742.00K | -27.2% |
| Q3 FY2021 | Sep 30, 2021 | $470.00K | -25.3% |
| Q2 FY2021 | Jun 30, 2021 | $825.00K | -19.9% |
| Q1 FY2021 | Mar 31, 2021 | $499.00K | -67.2% |
| Q4 FY2020 | Dec 31, 2020 | $1.02M | -37.2% |
| Q3 FY2020 | Sep 30, 2020 | $629.00K | -72.3% |
| Q2 FY2020 | Jun 30, 2020 | $1.03M | -59.0% |
| Q1 FY2020 | Mar 31, 2020 | $1.52M | -56.0% |
| Q4 FY2019 | Dec 31, 2019 | $1.62M | -53.1% |
| Q3 FY2019 | Sep 30, 2019 | $2.27M | -2.5% |
| Q2 FY2019 | Jun 30, 2019 | $2.51M | -42.5% |
| Q1 FY2019 | Mar 31, 2019 | $3.46M | +50.0% |
| Q4 FY2018 | Dec 31, 2018 | $3.46M | +138.5% |
| Q3 FY2018 | Sep 30, 2018 | $2.33M | +23.9% |
| Q2 FY2018 | Jun 30, 2018 | $4.37M | +57.6% |
| Q1 FY2018 | Mar 31, 2018 | $2.31M | – |
| Q4 FY2017 | Dec 31, 2017 | $1.45M | – |
| Q3 FY2017 | Sep 30, 2017 | $1.88M | – |
| Q2 FY2017 | Jun 30, 2017 | $2.77M | – |
See a number that looks wrong?